These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 29485413)

  • 1. Upregulated EBI3 Correlates with Poor Outcome and Tumor Progression in Breast Cancer.
    Jiang J; Liu X
    Oncol Res Treat; 2018; 41(3):111-115. PubMed ID: 29485413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr Virus-Induced Gene 3 (EBI3) Blocking Leads to Induce Antitumor Cytotoxic T Lymphocyte Response and Suppress Tumor Growth in Colorectal Cancer by Bidirectional Reciprocal-Regulation STAT3 Signaling Pathway.
    Liang Y; Chen Q; Du W; Chen C; Li F; Yang J; Peng J; Kang D; Lin B; Chai X; Zhou K; Zeng J
    Mediators Inflamm; 2016; 2016():3214105. PubMed ID: 27247488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and significance of interleukin-35 in lesion tissue of oral lichen planus patients].
    Wang R; Liu F; Jiang N; Cai Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Jan; 53(1):13-19. PubMed ID: 29972958
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin 35 is an independent prognostic factor and a therapeutic target for nasopharyngeal carcinoma.
    Zhang Y; Sun H; Wu H; Tan Q; Xiang K
    Contemp Oncol (Pozn); 2015; 19(2):120-4. PubMed ID: 26034389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer.
    Cheang TY; Zhou HY; Chen W; Zhang B; Liu L; Yang J; Wang S; Li H
    J Transl Med; 2016 Feb; 14():54. PubMed ID: 26883017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated IL-19 in breast cancer promotes tumor progression and affects clinical outcome.
    Hsing CH; Cheng HC; Hsu YH; Chan CH; Yeh CH; Li CF; Chang MS
    Clin Cancer Res; 2012 Feb; 18(3):713-25. PubMed ID: 22186257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased CDK10 expression correlates with lymph node metastasis and predicts poor outcome in breast cancer patients - a short report.
    You Y; Li H; Qin X; Zhang Y; Song W; Ran Y; Gao F
    Cell Oncol (Dordr); 2015 Dec; 38(6):485-91. PubMed ID: 26392360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer.
    Li N; Zheng Y; Xuan C; Lin Z; Piao L; Liu S
    Int J Clin Exp Pathol; 2015; 8(10):12893-900. PubMed ID: 26722481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Epstein-Barr virus-induced gene 3 as a novel serum and tissue biomarker and a therapeutic target for lung cancer.
    Nishino R; Takano A; Oshita H; Ishikawa N; Akiyama H; Ito H; Nakayama H; Miyagi Y; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
    Clin Cancer Res; 2011 Oct; 17(19):6272-86. PubMed ID: 21849417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Chaperone-Like Role for EBI3 in Collaboration With Calnexin Under Inflammatory Conditions.
    Watanabe A; Mizoguchi I; Hasegawa H; Katahira Y; Inoue S; Sakamoto E; Furusaka Y; Sekine A; Miyakawa S; Murakami F; Xu M; Yoneto T; Yoshimoto T
    Front Immunol; 2021; 12():757669. PubMed ID: 34603342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating low IL-23: IL-35 cytokine ratio promotes progression associated with poor prognosisin breast cancer.
    Chen G; Liang Y; Guan X; Chen H; Liu Q; Lin B; Chen C; Huang M; Chen J; Wu W; Liang Y; Zhou K; Zeng J
    Am J Transl Res; 2016; 8(5):2255-64. PubMed ID: 27347332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients.
    Liu W; Xu Y; Guan H; Meng H
    Cancer Biomark; 2018; 22(3):487-493. PubMed ID: 29843213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
    Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Epstein-Barr virus-induced gene 3 in cervical cancer: Association with clinicopathological parameters and prognosis.
    Hou YM; Dong J; Liu MY; Yu S
    Oncol Lett; 2016 Jan; 11(1):330-334. PubMed ID: 26870212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of IL-12 p40 and its homologue, Epstein-Barr virus-induced gene 3, in inflammatory bowel disease.
    Omata F; Birkenbach M; Matsuzaki S; Christ AD; Blumberg RS
    Inflamm Bowel Dis; 2001 Aug; 7(3):215-20. PubMed ID: 11515847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of MAGE-A9 predicts unfavorable outcome in breast cancer.
    Xu X; Tang X; Lu M; Tang Q; Zhang H; Zhu H; Xu N; Zhang D; Xiong L; Mao Y; Zhu J
    Exp Mol Pathol; 2014 Dec; 97(3):579-84. PubMed ID: 25445503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CDKN1A/p21 and TGFBR2 in breast cancer and their prognostic significance.
    Wei CY; Tan QX; Zhu X; Qin QH; Zhu FB; Mo QG; Yang WP
    Int J Clin Exp Pathol; 2015; 8(11):14619-29. PubMed ID: 26823785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer.
    Zhang XF; Liu T; Li Y; Li S
    Int J Clin Exp Pathol; 2015; 8(8):9440-5. PubMed ID: 26464701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-induced gene 3 commits human mesenchymal stem cells to differentiate into chondrocytes via endoplasmic reticulum stress sensor.
    Zhang T; Yamagata K; Iwata S; Sonomoto K; Trimova G; Nguyen AP; Hao H; Shan Y; Nguyen MP; Nakayamada S; Tanaka Y
    PLoS One; 2022; 17(12):e0279584. PubMed ID: 36548354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.